4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000062
EVP, Chief Scientific Officer sold 6,978 shares at $38.89 ($271,356)
- EVP, Chief Scientific Officer acquired 19,417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 1 in the form | +19,417 | 74,833 | D | ||
| 2023-01-18 | Sale : show line 2 in the form | −6,978 | $38.89 | $271,356 | 67,855 | D |
| Open-market sales · 6,978 sh · avg $38.89 · $271,356 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −19,417 | $0.00 | 19,417 | 21,414 | D |
Loading xslF345X03/edgardoc.xml…